The General Counsels Roundtable helps influential health law attorneys stay on top of or even ahead of changes in health law and policy. The roundtable connects GC to experts at HLS and the broader university, while also strengthening ties between faculty and legal practice.
This fall, the Harvard Law School Library hosted a series of book talks by Harvard Law School authors on topics ranging from forgiveness in law, transparency in health and fidelity in constitutional practice.
Zero-L, a new online course, is meant to help all incoming students, including those who don’t have any pre-law background. Featuring an array of Harvard Law School professors, it covers topics ranging from the separation of powers to how to speak in class in response to a cold call.
Calls are growing for the U.S. to lift a ban on mitochondrial replacement therapy, or MRT, a procedure developed to enable women who are at risk of passing on rare but devastating diseases to have healthy, biologically related children.
As part of a series called Focal Point, in which the Harvard Gazette asks a range of Harvard faculty members to answer the same question, I. Glenn Cohen explains why we should scrutinize what is and then ponder what should be.
In a lecture titled “The Second Reproductive Revolution,” I. Glenn Cohen, the faculty director of the Petrie-Flom Center, marked his appointment as the first James A. Attwood and Leslie Williams Professor of Law.
Library event provides unique opportunity for faculty-student interaction.
With the increased use of a massive volume and variety of data in our lives, our health care will inevitably be affected, note the editors of a new collection, one of the recent faculty books captured in this section.
Harvard researchers—including HLS Professor and Petrie-Flom Center Faculty Director Glenn Cohen—and others share their views on key issues in the field.
The Wall Street Journal investigative reporter whose new book chronicles the spectacular collapse of the blood-testing company Theranos and its alleged fraudulent activity told a Harvard audience that the fall is a cautionary tale for other high-tech firms aspiring to disrupt the health care industry.